ML385

ML385

Catalog Number:
L002372707APE
Mfr. No.:
APE-B8300
Price:
$220
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          ML385 is a novel and specific nuclear factor erythroid 2-related factor 2 (NRF2) inhibitor with an IC50 of 1.9 μM [1].
          NRF2, a redox sensitive basic leucine zipper (bZIP) transcription factor, has emerged as the “master regulator” of cell survival through coordinated induction of cytoprotective antioxidant genes, phase-II detoxification enzymes, multidrug transporters, and central metabolic pathways. Gain-of-function mutations in NRF2 are common in non-small cell lung cancer (NSCLC), associated with therapeutic resistance [1].
          In A549 cells, ML385 treatment at concentrations of 0 ~ 5 μM for 72 h dose-dependently reduced the expression levels of NRF2 and its target genes. At the concentration of 5 μM, a time-dependent decrease in NRF2 signaling could be observed in ML385-treated A549 cells, with the maximum decline at 72 h [1].
          In mouse models of human NSCLC, single agent Carboplatin (5 mg/kg, q.d., i.p.) or ML385 (30 mg/kg, q.d., i.p.)-treated groups had 42% and 57% of their pretreatment lung volume at 3 weeks, respectively, while the antitumor and anti-metastatic effect of Carboplatin and ML385 combination treatment was significantly obvious with 74% lung volume retention at 3 weeks [1].

      • Properties
        • Alternative Name
          2-(benzo[d][1,3]dioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)indolin-5-yl)thiazol-2-yl)acetamide
          CAS Number
          846557-71-9
          Molecular Formula
          C29H25N3O4S
          Molecular Weight
          511.59
          Purity
          98.00%
          Solubility
          insoluble in EtOH; insoluble in H2O; ≥13.33 mg/mL in DMSO
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Bo-Feng Yin, Zhi-Ling Li, et al. "Psoralen alleviates radiation-induced bone injury by rescuing skeletal stem cell stemness through AKT-mediated upregulation of GSK-3β and NRF2." Stem Cell Res Ther. 2022 Jun 7;13(1):241. PMID: 35672836
          2. Wen-ying Yang, Xiang Meng, et al. "PRDX6 Alleviates Lipopolysaccharide-induced Inflammation in Human Gingival Fibroblasts by Regulation of NRF2." Research Square. rs-1108989/v1.
          3. Xin Guo, Pingping Cao, et al. "The neuroprotective effect of phillyrin in intracerebral hemorrhagic mice is produced by activation of the Nrf2 signaling pathway." Eur J Pharmacol. 2021 Oct 15;909:174439. PMID: 34425100
          4. Jiapeng Hu, Jia Wang, et al."Fructose-1,6-bisphosphatase aggravates oxidative stress-induced apoptosis in asthma by suppressing the Nrf2 pathway." J Cell Mol Med. 2021 Jun;25(11):5001-5014. PMID: 33960626
          5. Fanrui Zhao, Chunlei Liu, et al. "Walnut-Derived Peptide Activates PINK1 via the NRF2/KEAP1/HO-1 Pathway, Promotes Mitophagy, and Alleviates Learning and Memory Impairments in a Mice Model." J Agric Food Chem. 2021 Mar 10;69(9):2758-2772. PMID: 33591165
          6. Shen X, Zhao Y, et al. "Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer." Life Sci. 2020;256:117923. PMID: 32522567
          7. Zheng K, Ma J, et al. "Sulforaphane Inhibits Autophagy and Induces Exosome-Mediated Paracrine Senescence via Regulating mTOR/TFE3." Mol Nutr Food Res. 2020;e1901231. PMID: 32476238

    We Also Recommend

    WST-1

    $410

    WST-1

    $464

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.